Fig. 2From: Tumor microenvironment-responsive fenton nanocatalysts for intensified anticancer treatmentCopyright 2018, American Chemical Society. c Schematic illustration for the fabrication of FAB NPs and the mechanisms of synergistic CDT/PDT/PTT therapy. Reproduced with permission. [33] Copyright 2021 Wiley‐VCHa The synthesis and cell endocytosis mechanism schematic diagram of FeGd-HN@Pt@LF/RGD2 NPs and intracellular effects of FeGd-HN@Pt@LF/RGD2 NPs on cancer cells [31]. b Percent survival of the mice bearing orthotopic brain tumors after treatment. Treatment with FeGd-HN@Pt2@LF/RGD2 significantly extended the survival of tumor-bearing mice. Reproduced with permission. [31]Back to article page